Mark Ma, MD (he/him/his)

VP, Head of Translational Clinical Sciences
Biotech
New Haven, Connecticut

Mark Ma is the VP, Head of Translational Clinical Sciences of Rallybio. Prior to Rallybio, Mark had taken several leadership roles at Alexion/AstraZeneca Pharmaceuticals and Amgen Inc, including the head of Bioanalytical and Biomarker Development and the Director of large Molecule Bioanalytical Science. Currently, Mark serves as the co-chair of Bioanalytical Community, AAPS.

Disclosure information not submitted.

Presentation(s):

• Rapid Fire: Sample Challenges, Yet Opportunities (BM)

  Tuesday, October 18, 2022
  3:00 PM – 4:00 PM ET

• Comparison of ICHM10 to previous BMV guidelines/LBA

  Wednesday, October 19, 2022
  3:45 PM – 4:00 PM ET